
Affiliated with a Castle Connolly Top Hospital
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
For detailed information, please contact Dr. Arai's office.
All Other Third Party
Blue Shield of California
Care N' Care
CVS Health (formerly Aetna)
Kaiser Permanente
Medicaid
Medicare
OptumRx
State of California
UnitedHealthcare
View All Insurances
The prognostic value of diagnosing concurrent multiple myeloma
BRITISH JOURL OF HAEMATOLOGY, 2013
H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2013
Heart transplantation and cardiac amyloidosis: Approach to screening and novel magement strategies
JOURL OF HEART AND LUNG TRANSPLANTATION, 2012
Long-term outcomes in patients with high
BONE MARROW TRANSPLANTATION, 2011
Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular
BRITISH JOURL OF HAEMATOLOGY, 2010
Infusion of the allogeneic cell line NK-92 in patients with advanced rel cell cancer or melanoma
CYTOTHERAPY, 2008
A cost-effectiveness alysis of adjuvant trastuzumab regimens in early HER2
JOURL OF CLINICAL ONCOLOGY, 2007
tural killer cells: can they be useful as adoptive immunotherapy for cancer?
Expert Opin Biol Ther, 2005
von Willebrand factor
The Hematology Jourl, 2001
The prognostic value of diagnosing concurrent multiple myeloma
BRITISH JOURNAL OF HAEMATOLOGY, 2013
H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2013
Prophylactic rituximab after allogeneic transplantation decreases B
BLOOD, 2012
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative
BONE MARROW TRANSPLANTATION, 2012
Heart transplantation and cardiac amyloidosis
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012
Adoptive Immunotherapy with Cytokine
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011
A phase 1 study of imatinib for corticosteroid-dependent
BLOOD, 2011
Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH
BLOOD, 2011
Early CMV Viremia Is Associated with Impaired Viral Control following Nonmyeloablative
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011
Long-term outcomes in patients with high
BONE MARROW TRANSPLANTATION, 2011
Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular
BRITISH JOURNAL OF HAEMATOLOGY, 2010
Phase I/II Trial of GN-BVC,
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010
Rituximab in hematopoietic cell transplantation
EXPERT OPINION ON BIOLOGICAL THERAPY, 2010
TLI and ATG conditioning with low risk of graft-versus
BLOOD, 2009
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma
CYTOTHERAPY, 2008
A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2
JOURNAL OF CLINICAL ONCOLOGY, 2007
Natural killer cells: can they be useful as adoptive immunotherapy for cancer?
Expert Opin Biol Ther, 2005
Association of Foxp3 regulatory gene expression and graft-versus-host disease
Blood, 2004
Poor outcome in steroid refractory GVHD with ATG treatment
Biol Blood Marrow Transplant, 2002
von Willebrand factor
The Hematology Journal, 2001